KA
Therapeutic Areas
Arcellx Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Anitocabtagene Autoleucel (anito-cel) | Relapsed/Refractory Multiple Myeloma | Phase 2 |
| ACLX-001 | Relapsed/Refractory Multiple Myeloma | Phase 1 |
| ACLX-002 | Relapsed/Refractory Acute Myeloid Leukemia (AML) & High-Risk MDS | Phase 1 |
| ACLX-003 | AML/MDS | Preclinical |
| ACLX-004 | AML/MDS | Preclinical |
| HCC Program | Hepatocellular Carcinoma | Discovery |
| SCLC Program | Small Cell Lung Cancer | Discovery |